Cell-based and stem-cell-based treatments for spinal cord injury: evidence from clinical trials

CM Zipser, JJ Cragg, JD Guest, MG Fehlings… - The Lancet …, 2022 - thelancet.com
Spinal cord injury is a severely disabling neurological condition leading to impaired mobility,
pain, and autonomic dysfunction. Most often, a single traumatic event, such as a traffic or …

Human iPSC-based models for the development of therapeutics targeting neurodegenerative lysosomal storage diseases

M Luciani, A Gritti, V Meneghini - Frontiers in Molecular Biosciences, 2020 - frontiersin.org
Lysosomal storage diseases (LSDs) are a group of rare genetic conditions. The absence or
deficiency of lysosomal proteins leads to excessive storage of undigested materials and …

Composite fibrin/carbon microfiber implants for bridging spinal cord injury: a translational approach in pigs

A Alves-Sampaio, P Del-Cerro… - International Journal of …, 2023 - mdpi.com
Biomaterials may enhance neural repair after spinal cord injury (SCI) and testing their
functionality in large animals is essential to achieve successful clinical translation. This work …

Induced pluripotent stem cell technology for spinal cord injury: a promising alternative therapy

Y Li, PP Shen, B Wang - Neural Regeneration Research, 2021 - journals.lww.com
Spinal cord injury has long been a prominent challenge in the trauma repair process. Spinal
cord injury is a research hotspot by virtue of its difficulty to treat and its escalating morbidity …

Challenges in advancing Schwann cell transplantation for spinal cord injury repair

JD Guest, AJ Santamaria, JP Solano… - Cytotherapy, 2025 - Elsevier
Abstract Background Aims In this article we aimed to provide an expert synthesis of the
current status of Schwann cell (SC) therapeutics and potential steps to increase their clinical …

[HTML][HTML] Optimal ratio of Wnt3a expression in human mesenchymal stem cells promotes axonal regeneration in spinal cord injured rat model

HH Yoon, HJ Lee, J Min, JH Kim… - Journal of Korean …, 2021 - synapse.koreamed.org
Objective Through our previous clinical trials, the demonstrated therapeutic effects of MSC in
chronic spinal cord injury (SCI) were found to be not sufficient. Therefore, the need to …

[HTML][HTML] Review of operative considerations in spinal cord stem cell therapy

PS Upadhyayula, JR Martin, RC Rennert… - World Journal of Stem …, 2021 - ncbi.nlm.nih.gov
Spinal cord injury (SCI) can permanently impair motor and sensory function and has a
devastating cost to patients and the United States healthcare system. Stem cell …

诱导多能干细胞技术治疗脊髓损伤: 一种有前途的替代疗法

Y Li, PP Shen, B Wang - 中国神经再生研究(英文版), 2021 - sjzsyj.com.cn
Spinal cord injury has long been a prominent challenge in the trauma repair process. Spinal
cord injury is a research hotspot by virtue of its difficulty to treat and its escalating morbidity …

Translational perspective: neuroregenerative strategies and therapeutics for traumatic spinal cord injury

AJ Santamaria, PM Saraiva, JP Solano… - Neural Repair and …, 2022 - Elsevier
The last three decades have witnessed transformative advances in biology and
neuroscience. Still, regeneration of axons after traumatic spinal cord injury (SCI) remains a …

A Stereotactic Device for Intraparenchymal Spinal Cord Injections: Latest Developments for Practical Clinical Use

T Federici, N Hardcastle, P Texakalidis… - Stereotactic and …, 2021 - karger.com
This manuscript introduces the latest generation of a patient-mounted platform designed for
segmental injections of therapeutics direct into the spinal cord parenchyma. It emphasizes …